Hapvida Participacoes e Investimentos SA
OTC:HAPVY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hapvida Participacoes e Investimentos SA
OTC:HAPVY
|
BR |
|
M
|
Matang Bhd
KLSE:MATANG
|
MY |
|
O
|
Oroco Resource Corp
F:OR6
|
CA |
|
A
|
Arix Bioscience PLC
F:3HY
|
UK |
|
Globalstar Inc
NASDAQ:GSAT
|
US |
|
China Aviation Oil (Singapore) Corporation Ltd
SGX:G92
|
SG |
|
N
|
New World Development Co Ltd
XMUN:NWDA
|
HK |
|
Li-Cycle Holdings Corp
OTC:LICYQ
|
CA |
|
G
|
GATX Corp
F:GAX
|
US |
Hapvida Participacoes e Investimentos SA
Hapvida is a Brazilian healthcare company that sells health insurance plans and also runs its own network of hospitals, clinics, emergency rooms, and diagnostic centers. It is not just an insurer or just a hospital chain; it combines both, which lets it control more of the patient journey from plan enrollment to treatment and testing. Its main customers are individuals and companies that buy medical coverage for employees, along with people who use its dental plans and private healthcare network. Hapvida makes money mainly by collecting monthly premiums from health plan members and by charging for medical and dental services inside its own network. Because it owns much of the care delivery system, it can keep more of the spending within the company instead of paying outside providers for everything. That integrated model is what sets Hapvida apart. In the Brazilian healthcare market, it acts as both payer and provider, which gives it direct exposure to insurance risk and clinical operations at the same time. This makes the business easier to understand as a combined membership-and-care platform rather than a pure insurer or a pure hospital operator.
Hapvida is a Brazilian healthcare company that sells health insurance plans and also runs its own network of hospitals, clinics, emergency rooms, and diagnostic centers. It is not just an insurer or just a hospital chain; it combines both, which lets it control more of the patient journey from plan enrollment to treatment and testing.
Its main customers are individuals and companies that buy medical coverage for employees, along with people who use its dental plans and private healthcare network. Hapvida makes money mainly by collecting monthly premiums from health plan members and by charging for medical and dental services inside its own network. Because it owns much of the care delivery system, it can keep more of the spending within the company instead of paying outside providers for everything.
That integrated model is what sets Hapvida apart. In the Brazilian healthcare market, it acts as both payer and provider, which gives it direct exposure to insurance risk and clinical operations at the same time. This makes the business easier to understand as a combined membership-and-care platform rather than a pure insurer or a pure hospital operator.
Turnaround: Management framed 2026 as a year of tighter execution, with a major push to simplify operations, decentralize decisions, and improve discipline across the company.
Commercial reset: Hapvida is revising products, pricing, and broker relationships market by market, and said the new approach is already helping retail net adds in the São Paulo metro area.
Member trend: The company lost 44,500 members in the quarter, mostly in São Paulo, but said that was better than last quarter and better than Q1 2025.
Cost caution: Management said Q1 medical costs were helped by seasonality, but March was stronger than expected and April was still above normal, so it remains cautious on health care costs next quarter.
Cash and balance sheet: Cash generation improved sharply, with net cash generation of BRL 478 million and leverage at 1.38x EBITDA, even after a BRL 200 million legacy payment.
Capital allocation: The company is reviewing its footprint and asset portfolio and is open to selling or closing units where it improves returns and accelerates deleveraging.
